EIF2A and infection: In vivo, in rats, infection with a mutant bacterial strain that does not produce pyocianin and, thus, does not activate of the GCN2–eIF2α–ATF4 pathway results in higher number of colony-forming units in the lungs, more extensive alveolar wall thickening and higher mortality when compared to infection with the WT strain.